SrasV1, Main, Curation, bibRecord, 005705

SARS: responding to an unknown virus

Identifieur interne : 005705 ( Main/Curation ); précédent : 005704; suivant : 005706

SARS: responding to an unknown virus

Auteurs : P. A. Tambyah [Singapour]

Source :

European Journal of Clinical Microbiology and Infectious Diseases [ 0934-9723 ] ; 2004-08-01.

RBID : ISTEX:C50B0B6EF89B17DB1DB6F6AF199D0D36D32E8A57

Descripteurs français

KwdFr :
- Analyse de survie, Contrôle des maladies contagieuses (organisation et administration), Coronavirus (isolement et purification), Femelle, Flambées de maladies, Humains, Incidence, Maladies transmissibles émergentes (), Maladies transmissibles émergentes (traitement médicamenteux), Maladies transmissibles émergentes (épidémiologie), Mise au point de programmes, Mâle, Organisation mondiale de la santé, Quarantaine, Santé mondiale, Singapour, Syndrome respiratoire aigu sévère (), Syndrome respiratoire aigu sévère (traitement médicamenteux), Syndrome respiratoire aigu sévère (épidémiologie), Virus du SRAS (isolement et purification), Voyage, Vêtements de protection, Évaluation de programme, Évaluation des risques.
MESH :
- isolement et purification : Coronavirus, Virus du SRAS.
- organisation et administration : Contrôle des maladies contagieuses.
- traitement médicamenteux : Maladies transmissibles émergentes, Syndrome respiratoire aigu sévère.
- épidémiologie : Maladies transmissibles émergentes, Syndrome respiratoire aigu sévère.
- Analyse de survie, Femelle, Flambées de maladies, Humains, Incidence, Maladies transmissibles émergentes, Mise au point de programmes, Mâle, Organisation mondiale de la santé, Quarantaine, Santé mondiale, Singapour, Syndrome respiratoire aigu sévère, Voyage, Vêtements de protection, Évaluation de programme, Évaluation des risques.
Pascal (Inist)
- Microbiologie, Syndrome respiratoire aigu sévère, Virus.
Wicri :
- geographic : Singapour.

English descriptors

KwdEn :
- Communicable Disease Control (organization & administration), Communicable Diseases, Emerging (drug therapy), Communicable Diseases, Emerging (epidemiology), Communicable Diseases, Emerging (prevention & control), Coronavirus (isolation & purification), Disease Outbreaks, Female, Global Health, Humans, Incidence, Male, Microbiology, Program Development, Program Evaluation, Protective Clothing, Quarantine, Risk Assessment, SARS Virus (isolation & purification), Severe Acute Respiratory Syndrome (drug therapy), Severe Acute Respiratory Syndrome (epidemiology), Severe Acute Respiratory Syndrome (prevention & control), Severe acute respiratory syndrome, Singapore, Survival Analysis, Travel, Virus, World Health Organization.
MESH :
- geographic : Singapore.
- drug therapy : Communicable Diseases, Emerging, Severe Acute Respiratory Syndrome.
- epidemiology : Communicable Diseases, Emerging, Severe Acute Respiratory Syndrome.
- isolation & purification : Coronavirus, SARS Virus.
- organization & administration : Communicable Disease Control.
- prevention & control : Communicable Diseases, Emerging, Severe Acute Respiratory Syndrome.
- Disease Outbreaks, Female, Global Health, Humans, Incidence, Male, Program Development, Program Evaluation, Protective Clothing, Quarantine, Risk Assessment, Survival Analysis, Travel, World Health Organization.

Abstract

Abstract: The severe acute respiratory syndrome (SARS) is an emerging infection caused by a novel coronavirus which first appeared in southern China at the end of 2002. In early 2003, through a single incident, it spread to Hong Kong, Singapore, Canada and Vietnam. For busy clinicians in large public hospitals, the response to the virus was initially based on ensuring a high level of protection for staff. However, as the epidemic progressed and more information became available about the virus, procedures were rationalized and the virus is currently under control worldwide. There are, however, numerous unanswered questions concerning super-spreading events, the modes of transmission of the virus and, perhaps most importantly, the rapid detection of the virus early in the course of disease. These issues need to be addressed in case the virus becomes more widespread in the near future.

Url:

DOI: 10.1007/s10096-004-1175-8

Links toward previous steps (curation, corpus...)

to stream Istex, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000081
to stream Istex, to step Curation: Pour aller vers cette notice dans l'étape Curation :000081
to stream Istex, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :001D83
to stream Pmc, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000533
to stream Pmc, to step Curation: Pour aller vers cette notice dans l'étape Curation :000533
to stream Pmc, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :001492
to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :002C64
to stream PubMed, to step Curation: Pour aller vers cette notice dans l'étape Curation :002C64
to stream PubMed, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :002A63
to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :000947
to stream Ncbi, to step Curation: Pour aller vers cette notice dans l'étape Curation :000947
to stream Ncbi, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :000947
to stream Main, to step Merge: Pour aller vers cette notice dans l'étape Curation :005B51
to stream PascalFrancis, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000811
to stream PascalFrancis, to step Curation: Pour aller vers cette notice dans l'étape Curation :000179
to stream PascalFrancis, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :000775
to stream Main, to step Merge: Pour aller vers cette notice dans l'étape Curation :005F26

Links to Exploration step

ISTEX:C50B0B6EF89B17DB1DB6F6AF199D0D36D32E8A57

Le document en format XML

<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">SARS: responding to an unknown virus</title>
<author><name sortKey="Tambyah, P A" sort="Tambyah, P A" uniqKey="Tambyah P" first="P. A." last="Tambyah">P. A. Tambyah</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:C50B0B6EF89B17DB1DB6F6AF199D0D36D32E8A57</idno>
<date when="2004" year="2004">2004</date>
<idno type="doi">10.1007/s10096-004-1175-8</idno>
<idno type="url">https://api.istex.fr/ark:/67375/VQC-R8B3CN6N-6/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000081</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000081</idno>
<idno type="wicri:Area/Istex/Curation">000081</idno>
<idno type="wicri:Area/Istex/Checkpoint">001D83</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001D83</idno>
<idno type="wicri:doubleKey">0934-9723:2004:Tambyah P:sars:responding:to</idno>
<idno type="wicri:source">PMC</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7088062</idno>
<idno type="RBID">PMC:7088062</idno>
<idno type="wicri:Area/Pmc/Corpus">000533</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000533</idno>
<idno type="wicri:Area/Pmc/Curation">000533</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000533</idno>
<idno type="wicri:Area/Pmc/Checkpoint">001492</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">001492</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:15252720</idno>
<idno type="wicri:Area/PubMed/Corpus">002C64</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002C64</idno>
<idno type="wicri:Area/PubMed/Curation">002C64</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002C64</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002A63</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002A63</idno>
<idno type="wicri:Area/Ncbi/Merge">000947</idno>
<idno type="wicri:Area/Ncbi/Curation">000947</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000947</idno>
<idno type="wicri:doubleKey">0934-9723:2004:Tambyah P:sars:responding:to</idno>
<idno type="wicri:Area/Main/Merge">005B51</idno>
<idno type="wicri:source">INIST</idno>
<idno type="RBID">Pascal:04-0491039</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000811</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000179</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000775</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000775</idno>
<idno type="wicri:doubleKey">0934-9723:2004:Tambyah P:sars:responding:to</idno>
<idno type="wicri:Area/Main/Merge">005F26</idno>
<idno type="wicri:Area/Main/Curation">005705</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">SARS: responding to an unknown virus</title>
<author><name sortKey="Tambyah, P A" sort="Tambyah, P A" uniqKey="Tambyah P" first="P. A." last="Tambyah">P. A. Tambyah</name>
<affiliation wicri:level="4"><country xml:lang="fr">Singapour</country>
<wicri:regionArea>Department of Medicine, National University of Singapore, 5 Lower Kent Ridge Road, 119074, Singapore</wicri:regionArea>
<orgName type="university">Université nationale de Singapour</orgName>
</affiliation>
<affiliation wicri:level="1"><country wicri:rule="url">Singapour</country>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">European Journal of Clinical Microbiology and Infectious Diseases</title>
<title level="j" type="abbrev">Eur J Clin Microbiol Infect Dis</title>
<idno type="ISSN">0934-9723</idno>
<idno type="eISSN">1435-4373</idno>
<imprint><publisher>Springer-Verlag; http://www.springer.de</publisher>
<pubPlace>Berlin/Heidelberg</pubPlace>
<date type="published" when="2004-08-01">2004-08-01</date>
<biblScope unit="volume">23</biblScope>
<biblScope unit="issue">8</biblScope>
<biblScope unit="page" from="589">589</biblScope>
<biblScope unit="page" to="595">595</biblScope>
</imprint>
<idno type="ISSN">0934-9723</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0934-9723</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Communicable Disease Control (organization & administration)</term>
<term>Communicable Diseases, Emerging (drug therapy)</term>
<term>Communicable Diseases, Emerging (epidemiology)</term>
<term>Communicable Diseases, Emerging (prevention & control)</term>
<term>Coronavirus (isolation & purification)</term>
<term>Disease Outbreaks</term>
<term>Female</term>
<term>Global Health</term>
<term>Humans</term>
<term>Incidence</term>
<term>Male</term>
<term>Microbiology</term>
<term>Program Development</term>
<term>Program Evaluation</term>
<term>Protective Clothing</term>
<term>Quarantine</term>
<term>Risk Assessment</term>
<term>SARS Virus (isolation & purification)</term>
<term>Severe Acute Respiratory Syndrome (drug therapy)</term>
<term>Severe Acute Respiratory Syndrome (epidemiology)</term>
<term>Severe Acute Respiratory Syndrome (prevention & control)</term>
<term>Severe acute respiratory syndrome</term>
<term>Singapore</term>
<term>Survival Analysis</term>
<term>Travel</term>
<term>Virus</term>
<term>World Health Organization</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Analyse de survie</term>
<term>Contrôle des maladies contagieuses (organisation et administration)</term>
<term>Coronavirus (isolement et purification)</term>
<term>Femelle</term>
<term>Flambées de maladies</term>
<term>Humains</term>
<term>Incidence</term>
<term>Maladies transmissibles émergentes ()</term>
<term>Maladies transmissibles émergentes (traitement médicamenteux)</term>
<term>Maladies transmissibles émergentes (épidémiologie)</term>
<term>Mise au point de programmes</term>
<term>Mâle</term>
<term>Organisation mondiale de la santé</term>
<term>Quarantaine</term>
<term>Santé mondiale</term>
<term>Singapour</term>
<term>Syndrome respiratoire aigu sévère ()</term>
<term>Syndrome respiratoire aigu sévère (traitement médicamenteux)</term>
<term>Syndrome respiratoire aigu sévère (épidémiologie)</term>
<term>Virus du SRAS (isolement et purification)</term>
<term>Voyage</term>
<term>Vêtements de protection</term>
<term>Évaluation de programme</term>
<term>Évaluation des risques</term>
</keywords>
<keywords scheme="MESH" type="geographic" xml:lang="en"><term>Singapore</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Communicable Diseases, Emerging</term>
<term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Communicable Diseases, Emerging</term>
<term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en"><term>Coronavirus</term>
<term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr"><term>Coronavirus</term>
<term>Virus du SRAS</term>
</keywords>
<keywords scheme="MESH" qualifier="organisation et administration" xml:lang="fr"><term>Contrôle des maladies contagieuses</term>
</keywords>
<keywords scheme="MESH" qualifier="organization & administration" xml:lang="en"><term>Communicable Disease Control</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Communicable Diseases, Emerging</term>
<term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Maladies transmissibles émergentes</term>
<term>Syndrome respiratoire aigu sévère</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Maladies transmissibles émergentes</term>
<term>Syndrome respiratoire aigu sévère</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Disease Outbreaks</term>
<term>Female</term>
<term>Global Health</term>
<term>Humans</term>
<term>Incidence</term>
<term>Male</term>
<term>Program Development</term>
<term>Program Evaluation</term>
<term>Protective Clothing</term>
<term>Quarantine</term>
<term>Risk Assessment</term>
<term>Survival Analysis</term>
<term>Travel</term>
<term>World Health Organization</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Analyse de survie</term>
<term>Femelle</term>
<term>Flambées de maladies</term>
<term>Humains</term>
<term>Incidence</term>
<term>Maladies transmissibles émergentes</term>
<term>Mise au point de programmes</term>
<term>Mâle</term>
<term>Organisation mondiale de la santé</term>
<term>Quarantaine</term>
<term>Santé mondiale</term>
<term>Singapour</term>
<term>Syndrome respiratoire aigu sévère</term>
<term>Voyage</term>
<term>Vêtements de protection</term>
<term>Évaluation de programme</term>
<term>Évaluation des risques</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Microbiologie</term>
<term>Syndrome respiratoire aigu sévère</term>
<term>Virus</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Singapour</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Abstract: The severe acute respiratory syndrome (SARS) is an emerging infection caused by a novel coronavirus which first appeared in southern China at the end of 2002. In early 2003, through a single incident, it spread to Hong Kong, Singapore, Canada and Vietnam. For busy clinicians in large public hospitals, the response to the virus was initially based on ensuring a high level of protection for staff. However, as the epidemic progressed and more information became available about the virus, procedures were rationalized and the virus is currently under control worldwide. There are, however, numerous unanswered questions concerning super-spreading events, the modes of transmission of the virus and, perhaps most importantly, the rapid detection of the virus early in the course of disease. These issues need to be addressed in case the virus becomes more widespread in the near future.</div>
</front>
</TEI>
<double idat="0934-9723:2004:Tambyah P:sars:responding:to"><INIST><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">SARS: responding to an unknown virus</title>
<author><name sortKey="Tambyah, P A" sort="Tambyah, P A" uniqKey="Tambyah P" first="P. A." last="Tambyah">P. A. Tambyah</name>
<affiliation wicri:level="4"><inist:fA14 i1="01"><s1>Department of Medicine, National University of Singapore, 5 Lower Kent Ridge Road</s1>
<s2>Singapore, 119074</s2>
<s3>SGP</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>Singapour</country>
<wicri:noRegion>Singapore, 119074</wicri:noRegion>
<orgName type="university">Université nationale de Singapour</orgName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">04-0491039</idno>
<date when="2004">2004</date>
<idno type="stanalyst">PASCAL 04-0491039 INIST</idno>
<idno type="RBID">Pascal:04-0491039</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000811</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000179</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000775</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000775</idno>
<idno type="wicri:doubleKey">0934-9723:2004:Tambyah P:sars:responding:to</idno>
<idno type="wicri:Area/Main/Merge">005F26</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">SARS: responding to an unknown virus</title>
<author><name sortKey="Tambyah, P A" sort="Tambyah, P A" uniqKey="Tambyah P" first="P. A." last="Tambyah">P. A. Tambyah</name>
<affiliation wicri:level="4"><inist:fA14 i1="01"><s1>Department of Medicine, National University of Singapore, 5 Lower Kent Ridge Road</s1>
<s2>Singapore, 119074</s2>
<s3>SGP</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>Singapour</country>
<wicri:noRegion>Singapore, 119074</wicri:noRegion>
<orgName type="university">Université nationale de Singapour</orgName>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">European journal of clinical microbiology & infectious diseases : (Print)</title>
<title level="j" type="abbreviated">Eur. j. clin. microbiol. infect. dis. : (Print)</title>
<idno type="ISSN">0934-9723</idno>
<imprint><date when="2004">2004</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">European journal of clinical microbiology & infectious diseases : (Print)</title>
<title level="j" type="abbreviated">Eur. j. clin. microbiol. infect. dis. : (Print)</title>
<idno type="ISSN">0934-9723</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Microbiology</term>
<term>Severe acute respiratory syndrome</term>
<term>Virus</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Syndrome respiratoire aigu sévère</term>
<term>Microbiologie</term>
<term>Virus</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The severe acute respiratory syndrome (SARS) is an emerging infection caused by a novel coronavirus which first appeared in southern China at the end of 2002. In early 2003, through a single incident, it spread to Hong Kong, Singapore, Canada and Vietnam. For busy clinicians in large public hospitals, the response to the virus was initially based on ensuring a high level of protection for staff. However, as the epidemic progressed and more information became available about the virus, procedures were rationalized and the virus is currently under control worldwide. There are, however, numerous unanswered questions concerning super-spreading events, the modes of transmission of the virus and, perhaps most importantly, the rapid detection of the virus early in the course of disease. These issues need to be addressed in case the virus becomes more widespread in the near future.</div>
</front>
</TEI>
</INIST>
<ISTEX><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">SARS: responding to an unknown virus</title>
<author><name sortKey="Tambyah, P A" sort="Tambyah, P A" uniqKey="Tambyah P" first="P. A." last="Tambyah">P. A. Tambyah</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:C50B0B6EF89B17DB1DB6F6AF199D0D36D32E8A57</idno>
<date when="2004" year="2004">2004</date>
<idno type="doi">10.1007/s10096-004-1175-8</idno>
<idno type="url">https://api.istex.fr/ark:/67375/VQC-R8B3CN6N-6/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000081</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000081</idno>
<idno type="wicri:Area/Istex/Curation">000081</idno>
<idno type="wicri:Area/Istex/Checkpoint">001D83</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001D83</idno>
<idno type="wicri:doubleKey">0934-9723:2004:Tambyah P:sars:responding:to</idno>
<idno type="wicri:source">PMC</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7088062</idno>
<idno type="RBID">PMC:7088062</idno>
<idno type="wicri:Area/Pmc/Corpus">000533</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000533</idno>
<idno type="wicri:Area/Pmc/Curation">000533</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000533</idno>
<idno type="wicri:Area/Pmc/Checkpoint">001492</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">001492</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:15252720</idno>
<idno type="wicri:Area/PubMed/Corpus">002C64</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002C64</idno>
<idno type="wicri:Area/PubMed/Curation">002C64</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002C64</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002A63</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002A63</idno>
<idno type="wicri:Area/Ncbi/Merge">000947</idno>
<idno type="wicri:Area/Ncbi/Curation">000947</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000947</idno>
<idno type="wicri:doubleKey">0934-9723:2004:Tambyah P:sars:responding:to</idno>
<idno type="wicri:Area/Main/Merge">005B51</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">SARS: responding to an unknown virus</title>
<author><name sortKey="Tambyah, P A" sort="Tambyah, P A" uniqKey="Tambyah P" first="P. A." last="Tambyah">P. A. Tambyah</name>
<affiliation wicri:level="4"><country xml:lang="fr">Singapour</country>
<wicri:regionArea>Department of Medicine, National University of Singapore, 5 Lower Kent Ridge Road, 119074, Singapore</wicri:regionArea>
<orgName type="university">Université nationale de Singapour</orgName>
</affiliation>
<affiliation wicri:level="1"><country wicri:rule="url">Singapour</country>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">European Journal of Clinical Microbiology and Infectious Diseases</title>
<title level="j" type="abbrev">Eur J Clin Microbiol Infect Dis</title>
<idno type="ISSN">0934-9723</idno>
<idno type="eISSN">1435-4373</idno>
<imprint><publisher>Springer-Verlag; http://www.springer.de</publisher>
<pubPlace>Berlin/Heidelberg</pubPlace>
<date type="published" when="2004-08-01">2004-08-01</date>
<biblScope unit="volume">23</biblScope>
<biblScope unit="issue">8</biblScope>
<biblScope unit="page" from="589">589</biblScope>
<biblScope unit="page" to="595">595</biblScope>
</imprint>
<idno type="ISSN">0934-9723</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0934-9723</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Communicable Disease Control (organization & administration)</term>
<term>Communicable Diseases, Emerging (drug therapy)</term>
<term>Communicable Diseases, Emerging (epidemiology)</term>
<term>Communicable Diseases, Emerging (prevention & control)</term>
<term>Coronavirus (isolation & purification)</term>
<term>Disease Outbreaks</term>
<term>Female</term>
<term>Global Health</term>
<term>Humans</term>
<term>Incidence</term>
<term>Male</term>
<term>Program Development</term>
<term>Program Evaluation</term>
<term>Protective Clothing</term>
<term>Quarantine</term>
<term>Risk Assessment</term>
<term>SARS Virus (isolation & purification)</term>
<term>Severe Acute Respiratory Syndrome (drug therapy)</term>
<term>Severe Acute Respiratory Syndrome (epidemiology)</term>
<term>Severe Acute Respiratory Syndrome (prevention & control)</term>
<term>Singapore</term>
<term>Survival Analysis</term>
<term>Travel</term>
<term>World Health Organization</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Analyse de survie</term>
<term>Contrôle des maladies contagieuses (organisation et administration)</term>
<term>Coronavirus (isolement et purification)</term>
<term>Femelle</term>
<term>Flambées de maladies</term>
<term>Humains</term>
<term>Incidence</term>
<term>Maladies transmissibles émergentes ()</term>
<term>Maladies transmissibles émergentes (traitement médicamenteux)</term>
<term>Maladies transmissibles émergentes (épidémiologie)</term>
<term>Mise au point de programmes</term>
<term>Mâle</term>
<term>Organisation mondiale de la santé</term>
<term>Quarantaine</term>
<term>Santé mondiale</term>
<term>Singapour</term>
<term>Syndrome respiratoire aigu sévère ()</term>
<term>Syndrome respiratoire aigu sévère (traitement médicamenteux)</term>
<term>Syndrome respiratoire aigu sévère (épidémiologie)</term>
<term>Virus du SRAS (isolement et purification)</term>
<term>Voyage</term>
<term>Vêtements de protection</term>
<term>Évaluation de programme</term>
<term>Évaluation des risques</term>
</keywords>
<keywords scheme="MESH" type="geographic" xml:lang="en"><term>Singapore</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Communicable Diseases, Emerging</term>
<term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Communicable Diseases, Emerging</term>
<term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en"><term>Coronavirus</term>
<term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr"><term>Coronavirus</term>
<term>Virus du SRAS</term>
</keywords>
<keywords scheme="MESH" qualifier="organisation et administration" xml:lang="fr"><term>Contrôle des maladies contagieuses</term>
</keywords>
<keywords scheme="MESH" qualifier="organization & administration" xml:lang="en"><term>Communicable Disease Control</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Communicable Diseases, Emerging</term>
<term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Maladies transmissibles émergentes</term>
<term>Syndrome respiratoire aigu sévère</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Maladies transmissibles émergentes</term>
<term>Syndrome respiratoire aigu sévère</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Disease Outbreaks</term>
<term>Female</term>
<term>Global Health</term>
<term>Humans</term>
<term>Incidence</term>
<term>Male</term>
<term>Program Development</term>
<term>Program Evaluation</term>
<term>Protective Clothing</term>
<term>Quarantine</term>
<term>Risk Assessment</term>
<term>Survival Analysis</term>
<term>Travel</term>
<term>World Health Organization</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Analyse de survie</term>
<term>Femelle</term>
<term>Flambées de maladies</term>
<term>Humains</term>
<term>Incidence</term>
<term>Maladies transmissibles émergentes</term>
<term>Mise au point de programmes</term>
<term>Mâle</term>
<term>Organisation mondiale de la santé</term>
<term>Quarantaine</term>
<term>Santé mondiale</term>
<term>Singapour</term>
<term>Syndrome respiratoire aigu sévère</term>
<term>Voyage</term>
<term>Vêtements de protection</term>
<term>Évaluation de programme</term>
<term>Évaluation des risques</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Singapour</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Abstract: The severe acute respiratory syndrome (SARS) is an emerging infection caused by a novel coronavirus which first appeared in southern China at the end of 2002. In early 2003, through a single incident, it spread to Hong Kong, Singapore, Canada and Vietnam. For busy clinicians in large public hospitals, the response to the virus was initially based on ensuring a high level of protection for staff. However, as the epidemic progressed and more information became available about the virus, procedures were rationalized and the virus is currently under control worldwide. There are, however, numerous unanswered questions concerning super-spreading events, the modes of transmission of the virus and, perhaps most importantly, the rapid detection of the virus early in the course of disease. These issues need to be addressed in case the virus becomes more widespread in the near future.</div>
</front>
</TEI>
</ISTEX>
</double>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 005705 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Curation/biblio.hfd -nk 005705 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Main
   |étape=   Curation
   |type=    RBID
   |clé=     ISTEX:C50B0B6EF89B17DB1DB6F6AF199D0D36D32E8A57
   |texte=   SARS: responding to an unknown virus
}}

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021

	Serveur d'exploration SRAS
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration SRAS

SARS: responding to an unknown virus

SARS: responding to an unknown virus

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri